Pemtumomab: Difference between revisions
m Protected "Pemtumomab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 36: | Line 36: | ||
{{mousemonoclonals}} | {{mousemonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 14:52, 20 August 2012
WikiDoc Resources for Pemtumomab |
Articles |
---|
Most recent articles on Pemtumomab |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pemtumomab at Clinical Trials.gov Clinical Trials on Pemtumomab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pemtumomab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pemtumomab Discussion groups on Pemtumomab Patient Handouts on Pemtumomab Directions to Hospitals Treating Pemtumomab Risk calculators and risk factors for Pemtumomab
|
Healthcare Provider Resources |
Causes & Risk Factors for Pemtumomab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Pemtumomab (formerly known as Theragyn) is a mouse monoclonal antibody which it's used to treat cancer.
External link
Template:Mousemonoclonals
Template:WH
Template:WikiDoc Sources